Clinical Trial Update: MRI Adaptive Replanning Using ViewRay [NA]

View source ↗

Summary

The clinical trial NCT02950792 evaluating MRI adaptive replanning with ViewRay for non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: University of Miami | Conditions: Non-Small Cell Lung Cancer | NA | Status: WITHDRAWN